InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: None

Tuesday, 04/29/2014 11:24:48 AM

Tuesday, April 29, 2014 11:24:48 AM

Post# of 1569
Needham:$15.00 Price Target - Buy Rating

Add a few shares before Tuesday's first quarter earnings report and conference call.

Potential $1 billion in milestone payments plus royalties from the company's other drugs.

Either Amgen or Astellas could make a buyout bid for the company at any time.

GLTA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTK News